Abstract

Background: Norbormide (NRB) is a selective rat toxicant endowed with vasoconstrictor activity confined to the rat peripheral arteries. In a recent work we used a fluorescent derivative of NRB (NRB-AF12), obtained by coupling the NBD fluorophore to the parent molecule via a linker, in order to gain information about the possible site of action of the unlabeled compound. We found that NRB-AF12 labeled intracellular organelles in both NRB-sensitive and -insensitive cells and we accordingly proposed its use as a scaffold for the development of a new class of fluorescent probes. In this study, we examined the fluorescent properties of a BODIPY FL-conjugated NRB probe (MC009) developed: (A) to verify if NRB distribution could be influenced by the attached fluorophore; (B) to improve the fluorescent performance of NRB-AF12.Methods: MC009 characteristics were investigated by confocal fluorescence microscopy, in freshly isolated rat caudal artery myocytes (FIRCAM) and in LX2 cells, representative of NRB-sensitive and insensitive cells, respectively.Main results: In both FIRCAM and LX2 cells MC009 stained endoplasmic reticulum, mitochondria, Golgi apparatus and lipid droplets, revealing the same intracellular distribution as NRB-AF12, and, at the same time, had both improved photostability and gave a more intense fluorescent signal at lower concentrations than was possible with NRB-AF12, which resulted in a better and finer visualization of intracellular structures. Furthermore, MC009 was effective in cellular labeling in both living and fixed cells. At the concentration used to stain the cells, MC009 did not show any cytotoxic effect and did not affect the regular progression of cell cycle and division.Conclusions: This study demonstrates that the distribution of fluorescently labeled NRB is not affected by the type of fluorophore attached to the parent compound, supporting the idea that the localization of the fluorescent derivatives may reasonably reflect that of the parent compound. In addition, we observed a marked improvement in the fluorescent properties of BODIPY FL-conjugated NRB (MC009) over its NBD-derived counterpart (NRB-AF12), confirming NRB as a scaffold for the development of new, high performance, non-toxic fluorescent probes for the labeling of intracellular structures in both living and fixed cells.

Highlights

  • Norbormide (NRB) is a very unique compound characterized by a species, tissue, and stereospecific biological activity that is lethal to rats, in which it induces a profound and irreversible vasoconstriction that has been associated to its toxic effect (Roszkowski, 1965; Poos et al, 1966; Bova et al, 2001; Cavalli et al, 2004; Rennison et al, 2007)

  • We investigated the biological properties of a boron dipyrromethene difluorides (BODIPYs) FL-conjugated NRB derivative (MC009), and confirmed that (i) it had the same distribution profile as NBDderived NRB-AF12 in NRB-contracted cells; (ii) it showed an improved fluorescent profile compared to NRB-AF12 with no apparent cytotoxic effects, indicating NRB as a suitable scaffold for the development of novel fluorescent probes for the labeling of cellular structures in both living and fixed cells

  • By analysing the excitation and emission peaks at 500 and 511 nm, respectively, we were able to confirm that the fluorescent spectrum of MC009 overlapped with that of the parent BODIPY FL fluorophore (Figure 1B)

Read more

Summary

Introduction

Norbormide (NRB) is a very unique compound characterized by a species (rat)-, tissue (vascular)-, and stereo (endo isomers)specific biological activity that is lethal to rats, in which it induces a profound and irreversible vasoconstriction that has been associated to its toxic effect (Roszkowski, 1965; Poos et al, 1966; Bova et al, 2001; Cavalli et al, 2004; Rennison et al, 2007). The molecular site of action and the mechanisms involved in the vasoconstrictor effect of NRB are unknown; it can be hypothesized, based on the features of its biological effect, the existence of a target that is exclusively expressed in the rat artery myocytes, or one that is part of a family expressed in the blood vessels of all animal species, but which has species-selective variants. The results of our previous work revealed that in all cell types investigated NRB-AF12 clearly labeled intracellular structures such as endoplasmic reticulum (ER), Golgi apparatus, mitochondria and some lysosomes, without inducing any apparent cytotoxic effect These findings suggested that an intracellular target could be involved in the vasoconstrictor effect of NRB and, at the same time, indicated NRB as a potential scaffold for the development of a new class of fluorescent probes for living cells (D’Amore et al, 2016). We examined the fluorescent properties of a BODIPY FL-conjugated NRB probe (MC009) developed: (A) to verify if NRB distribution could be influenced by the attached fluorophore; (B) to improve the fluorescent performance of NRB-AF12

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call